Join

Compare · EYE vs STAA

EYE vs STAA

Side-by-side comparison of National Vision Holdings Inc. (EYE) and STAAR Surgical Company (STAA): market cap, price performance, sector, and recent activity on the wire.

Summary

  • Both EYE and STAA operate in Ophthalmic Goods (Health Care), so they compete in similar markets.
  • STAA is the larger of the two at $1.49B, about 1.2x EYE ($1.24B).
  • Over the past year, EYE is down 23.8% and STAA is up 76.3% - STAA leads by 100.0 points.
  • STAA has been more active in the news (4 items in the past 4 weeks vs 2 for EYE).
  • STAA has more recent analyst coverage (25 ratings vs 20 for EYE).
PerformanceEYE-23.76%STAA+76.28%
2025-06-09+0.00%2026-06-08
MetricEYESTAA
Company
National Vision Holdings Inc.
STAAR Surgical Company
Price
$16.02+3.72%
$30.25+0.77%
Market cap
$1.24B
$1.49B
1M return
-29.81%
+10.89%
1Y return
-23.76%
+76.28%
Industry
Ophthalmic Goods
Ophthalmic Goods
Exchange
NASDAQ
NASDAQ
IPO
2017
News (4w)
2
4
Recent ratings
20
25
EYE

National Vision Holdings Inc.

National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. As of January 2, 2021, the company operated through 1,205 retail stores, as well as various e-commerce websites. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.

STAA

STAAR Surgical Company

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Latest EYE

Latest STAA